Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-13

Clinical Trial Update: Prevention av Autoimmunitet Med Laktobaciller [NA]

View source ↗

Summary

A completed Lund University trial investigates whether a Lactobacillus-based probiotic can prevent autoimmune diseases, including celiac disease, type 1 diabete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Lund University | Conditions: Celiac Disease in Children, Type 1 Diabetes | NA | Status: COMPLETED